Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018

In the early 2000s, a binary toxin (CDT)-producing strain of , ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in North America and Europe. This strain has not become established in Australia, and there is a markedly different repertoire of circulating strains there compared to...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical microbiology Vol. 58; no. 11
Main Authors Hong, Stacey, Putsathit, Papanin, George, Narelle, Hemphill, Christine, Huntington, Peter G, Korman, Tony M, Kotsanas, Despina, Lahra, Monica, McDougall, Rodney, Moore, Casey V, Nimmo, Graeme R, Prendergast, Louise, Robson, Jennifer, Waring, Lynette, Wehrhahn, Michael C, Weldhagen, Gerhard F, Wilson, Richard M, Riley, Thomas V, Knight, Daniel R
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 21.10.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In the early 2000s, a binary toxin (CDT)-producing strain of , ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in North America and Europe. This strain has not become established in Australia, and there is a markedly different repertoire of circulating strains there compared to other regions of the world. The Antimicrobial Resistance Surveillance (CDARS) study is a nationwide longitudinal surveillance study of infection (CDI) in Australia. Here, we describe the molecular epidemiology of CDI in Australian health care and community settings over the first 5 years of the study, 2013 to 2018. Between 2013 and 2018, 10 diagnostic microbiology laboratories from five states in Australia participated in the CDARS study. From each of five states, one private (representing community) and one public (representing hospitals) laboratory submitted isolates of or PCR-positive stool samples during two collection periods per year, February-March (summer/autumn) and August-September (winter/spring). was characterized by toxin gene profiling and ribotyping. A total of 1,523 isolates of were studied. PCR ribotyping yielded 203 different RTs, the most prevalent being RT014/020 (  = 449; 29.5%). The epidemic CDT RT027 (  = 2) and RT078 (  = 6), and the recently described RT251 (  = 10) and RT244 (  = 6) were not common, while RT126 (  = 17) was the most prevalent CDT type. A heterogeneous population was identified. RT014/020 was the most prevalent type found in humans with CDI. Continued surveillance of CDI in Australia remains critical for the detection of emerging strain lineages.
AbstractList In the early 2000s, a binary toxin (CDT)-producing strain of Clostridium difficile , ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in North America and Europe. This strain has not become established in Australia, and there is a markedly different repertoire of circulating strains there compared to other regions of the world. The C. difficile Antimicrobial Resistance Surveillance (CDARS) study is a nationwide longitudinal surveillance study of C. difficile infection (CDI) in Australia. In the early 2000s, a binary toxin (CDT)-producing strain of Clostridium difficile , ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in North America and Europe. This strain has not become established in Australia, and there is a markedly different repertoire of circulating strains there compared to other regions of the world. The C. difficile Antimicrobial Resistance Surveillance (CDARS) study is a nationwide longitudinal surveillance study of C. difficile infection (CDI) in Australia. Here, we describe the molecular epidemiology of CDI in Australian health care and community settings over the first 5 years of the study, 2013 to 2018. Between 2013 and 2018, 10 diagnostic microbiology laboratories from five states in Australia participated in the CDARS study. From each of five states, one private (representing community) and one public (representing hospitals) laboratory submitted isolates of C. difficile or PCR-positive stool samples during two collection periods per year, February-March (summer/autumn) and August-September (winter/spring). C. difficile was characterized by toxin gene profiling and ribotyping. A total of 1,523 isolates of C. difficile were studied. PCR ribotyping yielded 203 different RTs, the most prevalent being RT014/020 ( n  = 449; 29.5%). The epidemic CDT + RT027 ( n  = 2) and RT078 ( n  = 6), and the recently described RT251 ( n  = 10) and RT244 ( n  = 6) were not common, while RT126 ( n  = 17) was the most prevalent CDT + type. A heterogeneous C. difficile population was identified. C. difficile RT014/020 was the most prevalent type found in humans with CDI. Continued surveillance of CDI in Australia remains critical for the detection of emerging strain lineages.
In the early 2000s, a binary toxin (CDT)-producing strain of Clostridium difficile , ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in North America and Europe. This strain has not become established in Australia, and there is a markedly different repertoire of circulating strains there compared to other regions of the world. The C. difficile Antimicrobial Resistance Surveillance (CDARS) study is a nationwide longitudinal surveillance study of C. difficile infection (CDI) in Australia. ABSTRACT In the early 2000s, a binary toxin (CDT)-producing strain of Clostridium difficile , ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in North America and Europe. This strain has not become established in Australia, and there is a markedly different repertoire of circulating strains there compared to other regions of the world. The C. difficile Antimicrobial Resistance Surveillance (CDARS) study is a nationwide longitudinal surveillance study of C. difficile infection (CDI) in Australia. Here, we describe the molecular epidemiology of CDI in Australian health care and community settings over the first 5 years of the study, 2013 to 2018. Between 2013 and 2018, 10 diagnostic microbiology laboratories from five states in Australia participated in the CDARS study. From each of five states, one private (representing community) and one public (representing hospitals) laboratory submitted isolates of C. difficile or PCR-positive stool samples during two collection periods per year, February-March (summer/autumn) and August-September (winter/spring). C. difficile was characterized by toxin gene profiling and ribotyping. A total of 1,523 isolates of C. difficile were studied. PCR ribotyping yielded 203 different RTs, the most prevalent being RT014/020 ( n  = 449; 29.5%). The epidemic CDT + RT027 ( n  = 2) and RT078 ( n  = 6), and the recently described RT251 ( n  = 10) and RT244 ( n  = 6) were not common, while RT126 ( n  = 17) was the most prevalent CDT + type. A heterogeneous C. difficile population was identified. C. difficile RT014/020 was the most prevalent type found in humans with CDI. Continued surveillance of CDI in Australia remains critical for the detection of emerging strain lineages.
In the early 2000s, a binary toxin (CDT)-producing strain of , ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in North America and Europe. This strain has not become established in Australia, and there is a markedly different repertoire of circulating strains there compared to other regions of the world. The Antimicrobial Resistance Surveillance (CDARS) study is a nationwide longitudinal surveillance study of infection (CDI) in Australia. Here, we describe the molecular epidemiology of CDI in Australian health care and community settings over the first 5 years of the study, 2013 to 2018. Between 2013 and 2018, 10 diagnostic microbiology laboratories from five states in Australia participated in the CDARS study. From each of five states, one private (representing community) and one public (representing hospitals) laboratory submitted isolates of or PCR-positive stool samples during two collection periods per year, February-March (summer/autumn) and August-September (winter/spring). was characterized by toxin gene profiling and ribotyping. A total of 1,523 isolates of were studied. PCR ribotyping yielded 203 different RTs, the most prevalent being RT014/020 (  = 449; 29.5%). The epidemic CDT RT027 (  = 2) and RT078 (  = 6), and the recently described RT251 (  = 10) and RT244 (  = 6) were not common, while RT126 (  = 17) was the most prevalent CDT type. A heterogeneous population was identified. RT014/020 was the most prevalent type found in humans with CDI. Continued surveillance of CDI in Australia remains critical for the detection of emerging strain lineages.
Author Hemphill, Christine
Lahra, Monica
Putsathit, Papanin
George, Narelle
Wehrhahn, Michael C
Waring, Lynette
Kotsanas, Despina
Prendergast, Louise
Wilson, Richard M
Hong, Stacey
Korman, Tony M
Riley, Thomas V
Huntington, Peter G
Knight, Daniel R
McDougall, Rodney
Nimmo, Graeme R
Moore, Casey V
Robson, Jennifer
Weldhagen, Gerhard F
Author_xml – sequence: 1
  givenname: Stacey
  orcidid: 0000-0002-0482-7035
  surname: Hong
  fullname: Hong, Stacey
  organization: Medical, Molecular and Forensic Sciences, Murdoch University, Murdoch, WA, Australia
– sequence: 2
  givenname: Papanin
  orcidid: 0000-0001-9789-4239
  surname: Putsathit
  fullname: Putsathit, Papanin
  organization: School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia
– sequence: 3
  givenname: Narelle
  surname: George
  fullname: George, Narelle
  organization: Pathology Queensland, Royal Brisbane and Women's Hospital, Herston, QLD, Australia
– sequence: 4
  givenname: Christine
  surname: Hemphill
  fullname: Hemphill, Christine
  organization: Melbourne Pathology, Collingwood, VIC, Australia
– sequence: 5
  givenname: Peter G
  surname: Huntington
  fullname: Huntington, Peter G
  organization: Department of Microbiology, NSW Health Pathology, Royal North Shore Hospital, St Leonards, NSW, Australia
– sequence: 6
  givenname: Tony M
  surname: Korman
  fullname: Korman, Tony M
  organization: Monash Infectious Diseases, Monash University and Monash Health, Monash Medical Centre, Clayton, VIC, Australia
– sequence: 7
  givenname: Despina
  surname: Kotsanas
  fullname: Kotsanas, Despina
  organization: Monash Infectious Diseases, Monash University and Monash Health, Monash Medical Centre, Clayton, VIC, Australia
– sequence: 8
  givenname: Monica
  surname: Lahra
  fullname: Lahra, Monica
  organization: Department of Microbiology, The Prince of Wales Hospital, Randwick, NSW, Australia
– sequence: 9
  givenname: Rodney
  surname: McDougall
  fullname: McDougall, Rodney
  organization: Sullivan Nicolaides Pathology, Taringa, QLD, Australia
– sequence: 10
  givenname: Casey V
  surname: Moore
  fullname: Moore, Casey V
  organization: Microbiology and Infectious Diseases Laboratories, SA Pathology, Adelaide, SA, Australia
– sequence: 11
  givenname: Graeme R
  surname: Nimmo
  fullname: Nimmo, Graeme R
  organization: Pathology Queensland, Royal Brisbane and Women's Hospital, Herston, QLD, Australia
– sequence: 12
  givenname: Louise
  surname: Prendergast
  fullname: Prendergast, Louise
  organization: Melbourne Pathology, Collingwood, VIC, Australia
– sequence: 13
  givenname: Jennifer
  surname: Robson
  fullname: Robson, Jennifer
  organization: Sullivan Nicolaides Pathology, Taringa, QLD, Australia
– sequence: 14
  givenname: Lynette
  surname: Waring
  fullname: Waring, Lynette
  organization: Melbourne Pathology, Collingwood, VIC, Australia
– sequence: 15
  givenname: Michael C
  surname: Wehrhahn
  fullname: Wehrhahn, Michael C
  organization: Douglass Hanly Moir Pathology, Macquarie Park, NSW, Australia
– sequence: 16
  givenname: Gerhard F
  surname: Weldhagen
  fullname: Weldhagen, Gerhard F
  organization: Microbiology and Infectious Diseases Laboratories, SA Pathology, Adelaide, SA, Australia
– sequence: 17
  givenname: Richard M
  surname: Wilson
  fullname: Wilson, Richard M
  organization: Australian Clinical Labs, Microbiology Department, Wayville, SA, Australia
– sequence: 18
  givenname: Thomas V
  orcidid: 0000-0002-1351-3740
  surname: Riley
  fullname: Riley, Thomas V
  email: Thomas.riley@uwa.edu.au
  organization: Department of Microbiology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Nedlands, WA, Australia
– sequence: 19
  givenname: Daniel R
  orcidid: 0000-0002-9480-4733
  surname: Knight
  fullname: Knight, Daniel R
  organization: Medical, Molecular and Forensic Sciences, Murdoch University, Murdoch, WA, Australia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32848038$$D View this record in MEDLINE/PubMed
BookMark eNpVkU1v1DAQhi1URLeFG2fkYw-b4q8kzgWpRLRbtIjDgsTNcuxxa5TYre1U2hN_nQ0tFZzmMI_eeTXPCToKMQBCbyk5p5TJ95_7L-eE1jWrGHmBVpR0smoa8uMIrQjp6opS3h6jk5x_EkKFqOtX6JgzKSThcoV-bfUQky4x7auPOoPFuzk9gB9HHQzg6HA_xlySt36esPXOeeNHwNfBgSk-BuwDvpgPhB69DngDeiy3uNcJsA4W93Ga5uDLHu-gFB9u8hozQjkucZnyNXrp9JjhzdM8Rd8vP33rN9X269V1f7GtDJeiVLWzouGuk7Xj1hGqDVAOnFJnpdBDq0U7mMYSZttOc8rF4EQDxljZDSAZ56fow2Pu3TxMYA2EpbG6S37Saa-i9ur_TfC36iY-qLaWLemWgLOngBTvZ8hFTT4bWP4Ecc6KCd5KwdpmQdePqEkx5wTu-QwlanGmDs7UH2eKkQP-7t9qz_BfSfw3Fu2VcA
CitedBy_id crossref_primary_10_1111_tid_13758
crossref_primary_10_3390_antibiotics12071141
crossref_primary_10_1128_aem_00379_23
crossref_primary_10_1111_jam_15408
crossref_primary_10_1128_MRA_00599_21
crossref_primary_10_1093_jpids_piab057
crossref_primary_10_1016_j_pathol_2021_10_009
crossref_primary_10_1093_ofid_ofad232
crossref_primary_10_1099_mgen_0_001232
crossref_primary_10_1128_spectrum_03582_22
crossref_primary_10_2807_1560_7917_ES_2022_27_49_2200244
crossref_primary_10_1093_jac_dkab099
crossref_primary_10_3390_microorganisms11071743
crossref_primary_10_1007_s10096_023_04569_x
crossref_primary_10_1128_aac_00221_23
crossref_primary_10_1111_1462_2920_15821
crossref_primary_10_3390_genes13122200
Cites_doi 10.15620/cdc:82532
10.1128/AEM.03032-14
10.5694/j.1326-5377.2011.tb03012.x
10.1016/j.anaerobe.2019.06.003
10.2807/1560-7917.es2015.20.10.21059
10.1093/jac/dkv220
10.1016/j.jinf.2016.05.010
10.1111/imj.13027
10.1093/cid/ciu203
10.1128/mBio.00446-19
10.1086/671728
10.1002/nmi2.43
10.1111/jam.13653
10.1016/j.anaerobe.2018.11.009
10.3201/eid1407.071641
10.1056/NEJMoa1910215
10.5694/mja13.11153
10.1038/srep41196
10.1016/j.anaerobe.2019.03.008
10.1086/592257
10.1128/CMR.00082-09
10.1016/j.pathol.2016.10.013
10.1017/s0950268800049323
10.3389/fmicb.2016.02138
10.1128/AEM.01888-13
10.1016/j.pathol.2016.02.005
10.1016/j.cmi.2017.10.008
10.1016/S0140-6736(10)61266-4
10.1016/j.ajic.2012.03.009
ContentType Journal Article
Copyright Copyright © 2020 American Society for Microbiology.
Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology
Copyright_xml – notice: Copyright © 2020 American Society for Microbiology.
– notice: Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology
DBID NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1128/JCM.01552-20
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
CrossRef
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
DocumentTitleAlternate Surveillance of Clostridium difficile in Australia
EISSN 1098-660X
Editor Diekema, Daniel J.
Editor_xml – sequence: 1
  givenname: Daniel J.
  surname: Diekema
  fullname: Diekema, Daniel J.
ExternalDocumentID 10_1128_JCM_01552_20
32848038
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: ;
  grantid: RPG002-19
GroupedDBID ---
.55
0R~
18M
29K
2WC
39C
4.4
53G
5GY
5RE
5VS
ABOCM
ABPPZ
ACGFO
ADBBV
AENEX
AGVNZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CS3
D-I
DIK
DU5
E3Z
EBS
F5P
FRP
GX1
H13
HYE
HZ~
KQ8
L7B
NPM
O9-
OK1
P2P
P6G
RHF
RHI
RNS
RPM
RSF
TR2
UCJ
W8F
WOQ
X7M
ZCA
~KM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c384t-5fd463f985f3df01ace13e311fd84ab7a47bc6d02d79a3134bf46eccd89be8233
IEDL.DBID RPM
ISSN 0095-1137
IngestDate Tue Sep 17 21:11:18 EDT 2024
Fri Oct 25 03:59:47 EDT 2024
Thu Sep 12 16:33:26 EDT 2024
Sat Sep 28 08:28:06 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords molecular epidemiology
surveillance
Clostridium difficile
ribotyping
Language English
License Copyright © 2020 American Society for Microbiology.
All Rights Reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c384t-5fd463f985f3df01ace13e311fd84ab7a47bc6d02d79a3134bf46eccd89be8233
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Citation Hong S, Putsathit P, George N, Hemphill C, Huntington PG, Korman TM, Kotsanas D, Lahra M, McDougall R, Moore CV, Nimmo GR, Prendergast L, Robson J, Waring L, Wehrhahn MC, Weldhagen GF, Wilson RM, Riley TV, Knight DR. 2020. Laboratory-based surveillance of Clostridium difficile infection in Australian health care and community settings, 2013 to 2018. J Clin Microbiol 58:e01552-20. https://doi.org/10.1128/JCM.01552-20.
Present address: Peter G. Huntington, Department of Microbiology, The Prince of Wales Hospital, Randwick, NSW, Australia.
ORCID 0000-0001-9789-4239
0000-0002-9480-4733
0000-0002-1351-3740
0000-0002-0482-7035
OpenAccessLink https://doi.org/10.1128/jcm.01552-20
PMID 32848038
PQID 2437842763
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7587093
proquest_miscellaneous_2437842763
crossref_primary_10_1128_JCM_01552_20
pubmed_primary_32848038
PublicationCentury 2000
PublicationDate 20201021
PublicationDateYYYYMMDD 2020-10-21
PublicationDate_xml – month: 10
  year: 2020
  text: 20201021
  day: 21
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Journal of clinical microbiology
PublicationTitleAlternate J Clin Microbiol
PublicationYear 2020
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References Australian Comission on Safety and Quality in Health Care (e_1_3_3_10_2) 2018
e_1_3_3_17_2
e_1_3_3_16_2
e_1_3_3_19_2
e_1_3_3_18_2
e_1_3_3_12_2
Huber CA (e_1_3_3_13_2) 2014; 38
e_1_3_3_15_2
De Almeida MN (e_1_3_3_21_2) 2013; 126
e_1_3_3_34_2
e_1_3_3_14_2
e_1_3_3_32_2
e_1_3_3_33_2
e_1_3_3_11_2
e_1_3_3_30_2
Australian Commission on Safety and Quality in Health Care (e_1_3_3_5_2) 2011
e_1_3_3_31_2
e_1_3_3_6_2
e_1_3_3_8_2
e_1_3_3_7_2
e_1_3_3_28_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_24_2
e_1_3_3_23_2
e_1_3_3_26_2
e_1_3_3_25_2
e_1_3_3_2_2
e_1_3_3_20_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_3_2
References_xml – ident: e_1_3_3_3_2
  doi: 10.15620/cdc:82532
– ident: e_1_3_3_14_2
  doi: 10.1128/AEM.03032-14
– ident: e_1_3_3_18_2
  doi: 10.5694/j.1326-5377.2011.tb03012.x
– ident: e_1_3_3_29_2
  doi: 10.1016/j.anaerobe.2019.06.003
– ident: e_1_3_3_7_2
  doi: 10.2807/1560-7917.es2015.20.10.21059
– ident: e_1_3_3_9_2
  doi: 10.1093/jac/dkv220
– ident: e_1_3_3_28_2
  doi: 10.1016/j.jinf.2016.05.010
– ident: e_1_3_3_33_2
  doi: 10.1111/imj.13027
– ident: e_1_3_3_20_2
  doi: 10.1093/cid/ciu203
– ident: e_1_3_3_22_2
  doi: 10.1128/mBio.00446-19
– ident: e_1_3_3_31_2
  doi: 10.1086/671728
– ident: e_1_3_3_19_2
  doi: 10.1002/nmi2.43
– ident: e_1_3_3_26_2
  doi: 10.1111/jam.13653
– ident: e_1_3_3_8_2
  doi: 10.1016/j.anaerobe.2018.11.009
– ident: e_1_3_3_24_2
  doi: 10.3201/eid1407.071641
– ident: e_1_3_3_4_2
  doi: 10.1056/NEJMoa1910215
– ident: e_1_3_3_6_2
  doi: 10.5694/mja13.11153
– volume: 38
  start-page: E279
  year: 2014
  ident: e_1_3_3_13_2
  article-title: Surveillance snapshot of Clostridium difficile infection in hospitals across Queensland detects binary toxin producing ribotype UK 244
  publication-title: Commun Dis Intell Q Rep
  contributor:
    fullname: Huber CA
– ident: e_1_3_3_27_2
  doi: 10.1038/srep41196
– ident: e_1_3_3_30_2
  doi: 10.1016/j.anaerobe.2019.03.008
– volume: 126
  start-page: 9
  year: 2013
  ident: e_1_3_3_21_2
  article-title: Severe Clostridium difficile infection in New Zealand associated with an emerging strain, PCR-ribotype 244
  publication-title: N Z Med J
  contributor:
    fullname: De Almeida MN
– ident: e_1_3_3_23_2
  doi: 10.1086/592257
– ident: e_1_3_3_2_2
  doi: 10.1128/CMR.00082-09
– volume-title: Implementation guide for surveillance of Clostridium difficile infection
  year: 2011
  ident: e_1_3_3_5_2
  contributor:
    fullname: Australian Commission on Safety and Quality in Health Care
– ident: e_1_3_3_12_2
  doi: 10.1016/j.pathol.2016.10.013
– ident: e_1_3_3_32_2
  doi: 10.1017/s0950268800049323
– ident: e_1_3_3_15_2
  doi: 10.3389/fmicb.2016.02138
– volume-title: Clostridium difficile infection. Monitoring the national burden of Clostridium difficile
  year: 2018
  ident: e_1_3_3_10_2
  contributor:
    fullname: Australian Comission on Safety and Quality in Health Care
– ident: e_1_3_3_25_2
  doi: 10.1128/AEM.01888-13
– ident: e_1_3_3_11_2
  doi: 10.1016/j.pathol.2016.02.005
– ident: e_1_3_3_17_2
  doi: 10.1016/j.cmi.2017.10.008
– ident: e_1_3_3_16_2
  doi: 10.1016/S0140-6736(10)61266-4
– ident: e_1_3_3_34_2
  doi: 10.1016/j.ajic.2012.03.009
SSID ssj0014455
Score 2.4787672
Snippet In the early 2000s, a binary toxin (CDT)-producing strain of , ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in North America and...
In the early 2000s, a binary toxin (CDT)-producing strain of Clostridium difficile , ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
SubjectTerms Bacteriology
Title Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018
URI https://www.ncbi.nlm.nih.gov/pubmed/32848038
https://search.proquest.com/docview/2437842763
https://pubmed.ncbi.nlm.nih.gov/PMC7587093
Volume 58
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB51K1H1gqC8lkJlJLjh3fiR2DnCiqoUFoFKpd4iJ7bVlXaTaptF2lP_OmMnKS3cOOWQ2IryjeYRfzMfwFvFWCm4clTz0lCJBQANY-Bo7rmRutK2NKFReP4tOzmXpxfpxQ6kQy9MJO1X5WJSL1eTenEZuZVXq2o68MSm3-czzHEVVuLTEYzQQIcSvT86kDLtZAvylDIm1MB253p6OptP4swxtI192BPomnUSOlPuhqR_8sy_6ZJ34s_xI3jYJ47kQ_eCj2HH1QfwoJOS3B7A3rw_JH8CN187YJv1ln7EIGXJ2Wb9ywV5IUSYNJ7Mlk2Q67CLzYoEhRRcuHTkc8_LqsmiJn_-gZCuU4mETiViakv6npJ2S85cZE1fvycY4AVpm3DVT-H8-NPP2QntdRZoJbRsaeqtzITPdeqF9QkzlYv_Rpm3WppSGanKKrMJtyo3gglZepkh9FbnpdNciGewWze1ewHEeuVYag16ERnEy02O3jYxxuG2PKvcGN4Nn7q46sZpFLEM4bpAdIqITsGTMbwZcCjQ3sMhhqlds7kuwgBFLTm6xTE873C53WkAdAzqHmK3D4RZ2vfvoInFmdq9Sb3875WHsM9DKY5hjbNXsNuuN-415itteQSjLz_0UbTS304i6yg
link.rule.ids 230,315,730,783,787,888,27938,27939,53806,53808
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIkovPEppl6eR4Iazie0kzhFWVNuyqZDaot4iO3bEit2k2iZIy4W_zjiP0pYTnHJwbCWa8Tzsb74BeBsHgeYstlQyrajABIA6GjiaFEwJmUujlSsUTo-j6Zk4Og_PNyAcamFa0H6u5165WHrl_FuLrbxY5uMBJzb-kk4wxo0xEx_fgbu4X_1oSNL7ywMhwq5xQRLSIODxgHdncnw0Sb2WdQy1Yxu2OBpn6bvalOtO6a9I8zZg8poHOngIX4dv74An372m1l7-8xat4z__3CN40Mek5EM3_Bg2bLkD97oulesd2Er7-_cn8GvW6Uy1WtOP6P8MOWlWP6zrXITKQ6qCTBaV6wRi5s2SuOYrOHFhyWEP-SrJvCR_jldIVwRFXBEUUaUhfblKvSYntgVkX74nGDtwUlfuKXfh7ODT6WRK-xYONOdS1DQsjIh4kciw4KbwA5Xb9tg1KIwUSsdKxDqPjM9MnCgecKELEaFWGZloKxnnT2GzrEq7D8QUsQ1Co9BACdcXXSVoyH2lLC7LotyO4N0gw-yiY-rI2gyHyQzFnrViz5g_gjeDgDPcSu5-RJW2ai4zx80oBUOLO4K9TuBXKw2aMoL4hipcveBoum-OoIBbuu5eoM_-e-ZruD89TWfZ7PD483PYZi7jR-_JghewWa8a-xLDolq_ajfBbyHADEE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BEateeJTX8jQS3MjLdhLnCAurtnSrSqVSxSWyY1us2E1W2wRpufDXGedRtuXWUw6xrUQznof9zXwA79IoUoymxhNUSY9jAuC5NnBeZqnkohBaSVcoPDtO9s_44Xl8vkX11YL2CzX3y8XSL-c_WmzlalkEA04sOJlNMMZNMRMPVtoGt-EO7tlQDIl6f4HAedyRF2SxF0UsHTDvVASHk5nfdh5DDdmFEUMDLUJXn7LtmP6LNq-DJre80PQ-fB--vwOf_PSbWvnF72utHW_0gw_gXh-bko_dkIdwy5R7cLdjq9zswWjW38M_gj9Hne5U6433Cf2gJqfN-pdxDEaoRKSyZLKoHCOInjdL4khYcOLCkIMe-lWSeUn-HbOQrhiKuGIoIktN-rKVekNOTQvMvvhAMIZgpK7cUzyGs-mXb5N9r6dy8AomeO3FVvOE2UzElmkbRrIw7fFrZLXgUqWSp6pIdEh1mkkWMa4sT1C7tMiUEZSxJ7BTVqV5BkTb1ESxlmiouONHlxka9FBKg8vSpDBjeD_IMV91HTvyNtOhIkfR563ocxqO4e0g5By3lLsnkaWpmovc9WgUnKLlHcPTTuiXKw3aMob0ijpcDnDtuq--QSG3bbt7oT6_8cw3MDr5PM2PDo6_voBd6hJ_dKI0egk79boxrzA6qtXrdh_8BY09DsE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Laboratory-Based+Surveillance+of+Clostridium+difficile+Infection+in+Australian+Health+Care+and+Community+Settings%2C+2013+to+2018&rft.jtitle=Journal+of+clinical+microbiology&rft.au=Hong%2C+Stacey&rft.au=Putsathit%2C+Papanin&rft.au=George%2C+Narelle&rft.au=Hemphill%2C+Christine&rft.date=2020-10-21&rft.issn=0095-1137&rft.eissn=1098-660X&rft.volume=58&rft.issue=11&rft_id=info:doi/10.1128%2FJCM.01552-20&rft.externalDBID=n%2Fa&rft.externalDocID=10_1128_JCM_01552_20
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0095-1137&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0095-1137&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0095-1137&client=summon